Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
startups
biotech
acute migrane
bain capital
bausch health
biology
breast cancer
cancer
carla grandori
clinical trials
desmoid tumor
dihydroergotamine
dihydroergotamine mesylate
drug development
drugs
endeavor
exit
exoskeleton
funding
fundings & exits
fundraising
generic drug
glaxosmithkline
health
health/life sciences
impel neuropharma
life sciences
m&a
medical device
migraine
multiple myeloma
national blog main
national organization for rare disorders
new york
new york blog main
new york top stories
nirogacestat
orbimed
ottobock
peter diamandis
What
spinout
4
×
startup
drug
medicine
million
acquire
activity
aid
announced
area
based
bay
berkeley’s
biopharmaceutical
biotech
builds
called
cancer
celgene
cells
celularity
commercialize
companies
company
creating
days
deal
derived
device
diamandis
discovery
dog
drugs
endeavor
entered
exoskeleton
exoskeletons
fellow
firm
focus
Language
unset
Current search:
spinout
×
@techcrunch.com
2 years ago
Ottobock set to acquire fellow robotic exoskeleton maker SuitX
@geekwire.com
4 years ago
Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient’s tumors
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas